Effects of interleukin-1 beta, interleukin-6, and tumor necrosis factor on sensitivity of dorsal root ganglion and peripheral receptive fields in rats

被引:120
作者
Oezaktay, A. Cueneyt
Kallakuri, Srinivasu
Takebayashi, Tsuneo
Cavanaugh, John M.
Asik, Ibrahim
DeLeo, Joyce A.
Weinstein, James N.
机构
[1] Wayne State Univ, Ctr Bioengn, Detroit, MI 48201 USA
[2] Ankara Univ, Sch Med, Ibn I Sina HOsp, Dept Anesthesiol & Intens Care, TR-06100 Ankara, Turkey
[3] Dartmouth Coll, Hitchcock Med Ctr, Dept Anesthesiol & Pharmacol, Lebanon, NH 03756 USA
[4] Dartmouth Coll, Hitchcock Med Ctr, Dept Orthoped Surg, Lebanon, NH 03756 USA
关键词
interleukin-1; beta; interleukin-6; tumor necrosis factor; dorsal root ganglion; mechanosensitivity;
D O I
10.1007/s00586-005-0058-8
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
This study was designed to characterize the effects of low doses (0.5-5 ng) of pro-inflammatory cytokines, interleukin-1 beta (IL-1 beta), interleukin-6 (IL-6), and tumor necrosis factor (TNF), on the neural activity of dorsal root ganglion (DRG) in rats. The purpose of this study was to examine the effects of cytokines (IL-1 beta, IL-6, and TNF) on the somatosensory neural response of DRG. The release of inflammatory cytokines by an injured disc may play a critical role in pain production at nerve endings, axons, and nerve cell bodies. Herniated disc tissue has been shown to release IL-1 beta, IL-6, TNF, and other algesic chemicals. Their effects on nerve endings in disc and adjacent tissue may lead to low back pain and their effects on dorsal root axons and ganglia may lead to sciatica. Exposed lumbar DRGs were investigated by electrophysiologic techniques. Sham (mineral oil), control (carrier solution), or IL-1 beta, IL-6, or TNF at doses of 0.5, 1, and 5 ng were applied over the DRG. Baseline discharge rates as well as mechanosensitivity of the DRG and peripheral receptive fields were evaluated over 30 min. Applications of IL-1 beta at 1 ng resulted in an increase in the discharge rate, 5 ng resulted in an increased mechanosensitivity of the DRG in group II units. Similarly, after 1 ng TNF applications, group II units also showed an increase in mechanosensitivity of DRG and peripheral receptive fields. At low doses IL-1 beta and TNF sensitization of receptive fields were observed. The responses observed in the group II units indicate that a sub-population of afferent units might have long-term effects modifying the sensory input to the central nervous system. This study provides added evidence to the role of cytokines in modulating afferent activity following inflammation.
引用
收藏
页码:1529 / 1537
页数:9
相关论文
共 41 条
[1]   Local application of disc-related cytokines on spinal nerve roots [J].
Aoki, Y ;
Rydevik, B ;
Kikuchi, S ;
Olmarker, K .
SPINE, 2002, 27 (15) :1614-1617
[2]  
Bianchi M, 1998, J NEUROSCI RES, V53, P645, DOI 10.1002/(SICI)1097-4547(19980915)53:6<645::AID-JNR2>3.0.CO
[3]  
2-5
[4]   Intervertebral discs which cause low back pain secrete high levels of proinflammatory mediators [J].
Burke, JG ;
Watson, RWG ;
McCormack, D ;
Dowling, FE ;
Walsh, MG ;
Fitzpatrick, JM .
JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME, 2002, 84B (02) :196-201
[5]   Effects of nucleus pulposus on nerve root neural activity, mechanosensitivity, axonal morphology, and sodium channel expression [J].
Chen, CY ;
Cavanaugh, JM ;
Song, Z ;
Takebayashi, T ;
Kallakuri, S ;
Wooley, PH .
SPINE, 2004, 29 (01) :17-25
[6]   THE PIVOTAL ROLE OF TUMOR-NECROSIS-FACTOR-ALPHA IN THE DEVELOPMENT OF INFLAMMATORY HYPERALGESIA [J].
CUNHA, FQ ;
POOLE, S ;
LORENZETTI, BB ;
FERREIRA, SH .
BRITISH JOURNAL OF PHARMACOLOGY, 1992, 107 (03) :660-664
[7]   Neuropathic pain from an experimental neuritis of the rat sciatic nerve [J].
Eliav, E ;
Herzberg, U ;
Ruda, MA ;
Bennett, GJ .
PAIN, 1999, 83 (02) :169-182
[8]   INTERLEUKIN-1-BETA AS A POTENT HYPERALGESIC AGENT ANTAGONIZED BY A TRIPEPTIDE ANALOG [J].
FERREIRA, SH ;
LORENZETTI, BB ;
BRISTOW, AF ;
POOLE, S .
NATURE, 1988, 334 (6184) :698-701
[9]   CUTANEOUS HYPERALGESIA INDUCED BY PERIPHERAL INJECTION OF INTERLEUKIN-1-BETA IN THE RAT [J].
FUKUOKA, H ;
KAWATANI, M ;
HISAMITSU, T ;
TAKESHIGE, C .
BRAIN RESEARCH, 1994, 657 (1-2) :133-140
[10]  
GARABEDIAN BS, 1995, BRIT J PHARMACOL, V115, P1265